Owlstone Medical Ltd (Owlstone Medical) is a diagnostic company that develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications, Lonestar for disease biomarker detection and ATLAS for volatile organic compounds sampling from clinical sample. Owlstone Medical provides UltraFAIMS for enhanced mass spectrometry for medical research simulated human breath (SiHuB) products, CASPER that provides clean air supply for portable use in clinics and respiration collector for in vitro analysis (ReCIVA) breath sampler. The company’s products are used in applications such as lung cancer, asthma, tuberculosis, bowel (colorectal) cancer, coeliac disease and irritable bowel syndrome, inflammatory bowel disease, drug metabolites in urine, and propofol detection and monitoring. It operates offices in Cambridge and London, the UK. Owlstone Medical is headquartered in Cambridge, England, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Owlstone Medical Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Owlstone Medical Ltd Company Overview
- Owlstone Medical Ltd Company Snapshot
- Owlstone Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Owlstone Medical Ltd - Pipeline Analysis Overview
- Owlstone Medical Ltd - Key Facts
- Owlstone Medical Ltd - Major Products and Services
- Owlstone Medical Ltd Pipeline Products by Development Stage
- Owlstone Medical Ltd Ongoing Clinical Trials by Trial Status
- Owlstone Medical Ltd Pipeline Products Overview
- Breath Biopsy Digestive Health Test - Food Intolerance
- Breath Biopsy Digestive Health Test - Food Intolerance Product Overview
- Breath Biopsy Digestive Health Test - Small Intestine Bacterial Overgrowth
- Breath Biopsy Digestive Health Test - Small Intestine Bacterial Overgrowth Product Overview
- Breath Biopsy Test - HIV
- Breath Biopsy Test - HIV Product Overview
- Breath Biopsy Test - Pulmonary Hypertension
- Breath Biopsy Test - Pulmonary Hypertension Product Overview
- Breath Biopsy Test - Tuberculosis
- Breath Biopsy Test - Tuberculosis Product Overview
- Diagnostic Test - Aspergillus Lung Infection
- Diagnostic Test - Aspergillus Lung Infection Product Overview
- Diagnostic Test - Aspergillus Lung Infection Clinical Trial
- Diagnostic Test - Lung Transplant Rejection
- Diagnostic Test - Lung Transplant Rejection Product Overview
- ReCIVA Breath Sampler - Cancer
- ReCIVA Breath Sampler - Cancer Product Overview
- ReCIVA Breath Sampler - Colorectal Cancer
- ReCIVA Breath Sampler - Colorectal Cancer Product Overview
- ReCIVA Breath Sampler - Lung Cancer
- ReCIVA Breath Sampler - Lung Cancer Product Overview
- STRATA Breath Test
- STRATA Breath Test Product Overview
- Owlstone Medical Ltd - Key Competitors
- Owlstone Medical Ltd - Key Employees
- Owlstone Medical Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Owlstone Medical Ltd, Recent Developments
- Jan 16, 2025: Owlstone Medical secures $27m for Breath Biopsy platform development
- Apr 25, 2024: Owlstone Medical Secures $6.5 Million to Support Development of Breath-Based Diagnostics for Infectious Disease
- Apr 25, 2024: Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease
- Dec 09, 2023: Owlstone Medical Publishes Data on the use of an EVOC Probe for the Early Detection of Liver Cirrhosis
- Oct 10, 2023: Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy
- Jun 22, 2023: Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy Tests for Liver Cirrhosis and NASH
- Jun 14, 2023: Owlstone Medical Presents Data Demonstrating Progress in Development of Breath Biopsy Test for the Early Detection of Lung Cancer
- May 17, 2023: Owlstone Medical wins contract from U.S. Department of Defense to develop handheld breath biopsy device for early infectious disease detection
- Apr 04, 2023: Owlstone Medical Launches OMED Health to Enable Patients to Better Understand their Gut Microbiome and Manage their Digestive Health
- Feb 06, 2023: Owlstone Medical publishes data on the use of exhaled volatile organic compounds as biomarkers for liver disease detection
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Owlstone Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Owlstone Medical Ltd Pipeline Products by Equipment Type
- Owlstone Medical Ltd Pipeline Products by Indication
- Owlstone Medical Ltd Ongoing Clinical Trials by Trial Status
- Owlstone Medical Ltd, Key Facts
- Owlstone Medical Ltd, Major Products and Services
- Owlstone Medical Ltd Number of Pipeline Products by Development Stage
- Owlstone Medical Ltd Pipeline Products Summary by Development Stage
- Owlstone Medical Ltd Ongoing Clinical Trials by Trial Status
- Owlstone Medical Ltd Ongoing Clinical Trials Summary
- Breath Biopsy Digestive Health Test - Food Intolerance - Product Status
- Breath Biopsy Digestive Health Test - Food Intolerance - Product Description
- Breath Biopsy Digestive Health Test - Small Intestine Bacterial Overgrowth - Product Status
- Breath Biopsy Digestive Health Test - Small Intestine Bacterial Overgrowth - Product Description
- Breath Biopsy Test - HIV - Product Status
- Breath Biopsy Test - HIV - Product Description
- Breath Biopsy Test - Pulmonary Hypertension - Product Status
- Breath Biopsy Test - Pulmonary Hypertension - Product Description
- Breath Biopsy Test - Tuberculosis - Product Status
- Breath Biopsy Test - Tuberculosis - Product Description
- Diagnostic Test - Aspergillus Lung Infection - Product Status
- Diagnostic Test - Aspergillus Lung Infection - Product Description
- Diagnostic Test - Aspergillus Lung Infection - A Preliminary Clinical Study of Non-invasive Breath Diagnostic Technology for the Early and Accurate Detection of Organ Rejection
- Diagnostic Test - Lung Transplant Rejection - Product Status
- Diagnostic Test - Lung Transplant Rejection - Product Description
- ReCIVA Breath Sampler - Cancer - Product Status
- ReCIVA Breath Sampler - Cancer - Product Description
- ReCIVA Breath Sampler - Colorectal Cancer - Product Status
- ReCIVA Breath Sampler - Colorectal Cancer - Product Description
- ReCIVA Breath Sampler - Lung Cancer - Product Status
- ReCIVA Breath Sampler - Lung Cancer - Product Description
- STRATA Breath Test - Product Status
- STRATA Breath Test - Product Description
- Owlstone Medical Ltd, Key Employees
- Owlstone Medical Ltd, Other Locations
- Glossary
- Owlstone Medical Ltd Pipeline Products by Equipment Type
- Owlstone Medical Ltd Pipeline Products by Development Stage
- Owlstone Medical Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alcolock France SAS
- Cyprotex Discovery Ltd
- Abcodia Ltd
